InsiderClue
Insiders · Profile

Muralidhar Bali

Director at EXICURE · Director at OnKure Therapeutics · Director at SPRUCE BIOSCIENCES. Filing since 19 Dec 2019. CIK 0001784138

XCUR EXICURE, INC. Director · 2 trades OKUR OnKure Therapeutics, Inc. Director · 11 trades SPRB SPRUCE BIOSCIENCES, INC. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
XCUR EXICURE, INC.
19 May 2022
Director
Bought
1,472,126
$285.15K
21.1%
OKUR OnKure Therapeutics, Inc.
14 Jul 2021
Director
Bought
111,736
$949.76K
5.7%
OKUR OnKure Therapeutics, Inc.
23 Jun 2021
Director
Bought
20,710
$192.24K
1.1%
OKUR OnKure Therapeutics, Inc.
22 Jun 2021
Director
Bought
14,615
$127.49K
0.8%
OKUR OnKure Therapeutics, Inc.
21 Jun 2021
Director
Bought
32,659
$294.93K
1.7%
OKUR OnKure Therapeutics, Inc.
8 Jun 2021
Director
Bought
16,605
$157.71K
0.9%
OKUR OnKure Therapeutics, Inc.
4 Jun 2021
Director
Bought
257
$2.42K
0.0%
OKUR OnKure Therapeutics, Inc.
3 Jun 2021
Director
Bought
12,100
$111.94K
0.6%
OKUR OnKure Therapeutics, Inc.
28 May 2021
Director
Bought
14
$133.00
0.0%
OKUR OnKure Therapeutics, Inc.
27 May 2021
Director
Bought
1,120
$10.37K
0.1%
OKUR OnKure Therapeutics, Inc.
26 May 2021
Director
Bought
5,915
$55.50K
0.3%
OKUR OnKure Therapeutics, Inc.
13 Apr 2021
Director
Bought
200,000
$3.00M
12.1%
SPRB SPRUCE BIOSCIENCES, INC.
14 Oct 2020
Director
Bought
200,000
$3.00M
12.6%
XCUR EXICURE, INC.
19 Dec 2019
Director
Bought
727,000
$2.00M
11.6%
14 decisions on file.